Technology | October 14, 2011

Hologic Features Next Generation Multi-lumen Brachytherapy Applicator

Should cancer be detected in its early stages, many women are candidates for Hologic's targeted radiation therapy, a patient-friendly and effective alternative for women that qualify. At RSNA 2011, Hologic will feature its next generation MammoSite multi-lumen (ML) brachytherapy applicator.

For women with early-stage breast cancer, Hologic offers today’s most widely used form of partial breast irradiation: MammoSite five-day targeted radiation therapy. MammoSite therapy gives physicians an important tool for the practice of breast-conserving therapy, and it makes it easier for more women to consider the choice of lumpectomy, including some women who may have otherwise had a mastectomy to avoid lengthy conventional radiation therapy. Hologic continues to expand the horizon of Accelerated Partial Breast Irradiation (APBI) for early-stage breast cancer patients with its next generation MammoSite multi-lumen (ML) brachytherapy applicator. The MammoSite ML technology enables the ability to shift the radiation dose for a more precise target. This feature will result in more women being appropriate candidates for APBI.

For more information: www.hologic.com

Related Content

Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017
iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct intraoperative radiation...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Overlay Init